7.3 Medications, Diagnostic Tests, and Abbreviations as Clinical Indicators

Certified Clinical Documentation Specialist CCDS

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility Pathways and the 2,000-Hour Year 1.3 Allowed Resources and Test-Day Rules 1.4 Recertification, Fees, and How This Guide Maps the Eight Domains

2 IPPS Foundations

2.1 How IPPS Works and How CMS Updates It 2.2 MS-DRG Assignment, Relative Weights, and Grouping 2.3 Provider and Clinical Staff Documentation Duties under IPPS

3 Severity, CMI, Medical Necessity, and Oversight

3.1 CC versus MCC Recognition and CC Exclusion Lists 3.2 Case Mix Index and Why CDI Tracks It 3.3 Two-Midnight Rule, Medical Necessity of Setting, and Principal Diagnosis 3.4 MAC, RAC, CERT, OIG, and Denial-Vulnerable Practices

4 Nervous and Respiratory System CDI

4.1 Nervous System Conditions for CDI 4.2 Acute and Chronic Respiratory Failure, ABGs, and Ventilation Support 4.3 Pneumonia, COPD, PE, Pleural Effusion, and Respiratory Infections

5 Circulatory, Digestive, Hepatobiliary, Musculoskeletal, and Skin CDI

5.1 Circulatory Disorders 5.2 Digestive and Hepatobiliary Disorders 5.3 Musculoskeletal and Skin

6 Endocrine, Nutrition, Kidney, and Hematologic CDI

6.1 Diabetes, Dehydration, and Obesity 6.2 Malnutrition Criteria, Severity, and Audit Risk 6.3 AKI, CKD Staging, UTI, and Urinary Stones 6.4 Anemia, Coagulation, Sickle Cell, Lymphoma, and Leukemia

7 Infectious Disease, Other MDCs, and Clinical Indicator Tools

7.1 Sepsis, Severe Sepsis, Postoperative and Other Infections 7.2 Mental, Substance Use, Injuries/Toxicology, and HIV-Related Conditions 7.3 Medications, Diagnostic Tests, and Abbreviations as Clinical Indicators

8 Health Record Elements and Query Triggers

8.1 Which Record Elements Support Diagnosis and Procedure Codes 8.2 Attending versus Radiologist, Pathologist, and Other Providers 8.3 When a Physician Query Is Warranted 8.4 When Queries Are Not Appropriate

9 Query Timing, Verbal Queries, Formats, and Clinical Indicators

9.1 Concurrent, Retrospective, Pre-Bill, and Prospective Timing 9.2 Verbal Queries and Required Documentation 9.3 Open-Ended, Multiple-Choice, and Yes/No 9.4 Clinical Indicators and How to Source Them

10 Compliant Query Practice and Clinical Validation

10.1 Compliant versus Leading and Other Noncompliant Queries 10.2 ACDIS/AHIMA 2026 Guidelines for Achieving a Compliant Query Practice 10.3 Clinical Validation and Diagnoses without Clinical Support

11 CDI Program Metrics

11.1 Productivity, Query Volume, and Provider Response Rates 11.2 CMI, CC/MCC Capture, and High-Frequency DRGs 11.3 SOI/ROM as CDI Program Performance Metrics

12 Physician Metrics, PEPPER, Forecasting, and Public Data

12.1 Measuring Physician Documentation Performance 12.2 PEPPER, Forecasting, Hospital Financial Data, and Public Reporting

13 CDI Roles, Coder Collaboration, and Physician Education

13.1 Roles and Responsibilities of the CDI Specialist 13.2 Coder Roles Working with a CDI Department 13.3 Physician Education Tools, Forms, and Presentations

14 Provider Communication and DRG Reconciliation

14.1 Non-Confrontational Communication and When Verbal Beats Written 14.2 Working DRG versus Final DRG Reconciliation

15 Official Guidelines, Principal Diagnosis, and Secondary Diagnosis

15.1 Official Guidelines, Cooperating Parties, Updates, and AHA Coding Clinic 15.2 Principal Diagnosis Selection 15.3 Secondary Diagnosis Reporting Criteria

16 Sequencing, Coding Conventions, and POA Indicators

16.1 Sequencing When Two Diagnoses Equally Meet PD; Working DRG with Multiple Diagnoses 16.2 Integral Signs/Symptoms, the With Convention, and Uncertain Diagnoses 16.3 Present-on-Admission Indicator Assignment and Payment Impact

17 Hospital-Acquired Conditions, Disposition, and ICD-10-PCS Essentials

17.1 CMS Hospital-Acquired Condition Payment Provision 17.2 Discharge Disposition, Transfer Payment, Principal Procedure, and ICD-10-PCS Essentials

18 Ethics, Privacy, and Leading Queries as Compliance Failures

18.1 ACDIS Code of Ethics and CDI Goals beyond Reimbursement 18.2 HIPAA, Minimum Necessary, and Record Confidentiality 18.3 Leading Queries as a Compliance Failure

19 DRG Creep, OIG Oversight, PEPPER, and the False Claims Act

19.1 DRG Compliance, DRG Creep, and the OIG Work Plan 19.2 PEPPER Compliance Risks and the False Claims Act

20 Mortality Index, Observed-to-Expected Ratios, and Quality Data Sources

20.1 Documentation Impact on Mortality Index (SOI/ROM) 20.2 Mortality Reviews and Observed-to-Expected Ratios 20.3 Abstracted versus Claims-Based Quality Data

21 CMS Quality Programs, PSIs, and Infection versus Complication Codes

21.1 HVBP, HAC Reduction Program, HRRP, 30-Day Mortality, and Hospital IQR 21.2 PSI 90 Components and PSIs beyond the Composite 21.3 Healthcare-Associated Infections versus Complication Codes

7.3 Medications, Diagnostic Tests, and Abbreviations as Clinical Indicators

Key Takeaways Explain This Topic AI

Medications such as megestrol, vasopressors, insulin infusions, and lactulose are clinical indicators, not standalone diagnoses

Laboratory values and imaging reports support queries; they do not replace a provider diagnostic statement

Official Guidelines (Section III.B): abnormal findings are not coded and reported unless the provider indicates their clinical significance

If a finding is outside the normal range and the provider has ordered further testing or treatment, it is appropriate to ask whether the finding should be added

Standard abbreviations save time; ambiguous abbreviations (MS, PT, and similar) are dangerous and should be queried rather than guessed

Last updated: September 2026

7.3 Medications, Diagnostic Tests, and Abbreviations as Clinical Indicators

Quick Answer: Read drugs , labs , and imaging as clinical indicators . Megestrol (Megace) points toward poor appetite, not toward a coded malnutrition diagnosis by itself. Vasopressors point toward shock type that still needs a name. Insulin infusions point toward severe hyperglycemia, diabetic ketoacidosis, or a hyperosmolar state. Lactulose points toward hepatic encephalopathy. The ICD-10-CM Official Guidelines ( Section III.B ) say abnormal findings (laboratory, x-ray, pathologic, and other diagnostic results) are not coded unless the provider indicates their clinical significance . Ambiguous abbreviations must be clarified, not decoded in favor of an MCC.

This independent ExamFinch section helps inpatient CDI specialists study indicator literacy for the CCDS exam. It is not an ACDIS product and does not claim ACDIS approval or partnership. The CCDS sitting allows DRG Expert and one listed drug handbook ; those books help you interpret what a drug is used for. They still do not let you assign a diagnosis from the medication administration record ( MAR ).

Drugs are clues, not codes

A drug on the MAR tells you what the team is treating or preventing. It does not tell the grouper what to report. The provider diagnostic statement, plus UHDDS relevance for secondary diagnoses, still governs the claim.

Medication What it commonly indicates What it does not prove by itself

Megestrol acetate (Megace) Appetite stimulation; possible malnutrition, cachexia, or cancer-related wasting under evaluation Severe protein-calorie malnutrition or cachexia as a coded diagnosis

Norepinephrine, vasopressin, epinephrine, phenylephrine, dopamine Shock physiology; look for type (septic, cardiogenic, hypovolemic, obstructive) Septic shock or any shock type without a provider name

Insulin infusion Severe hyperglycemia, diabetic ketoacidosis, hyperosmolar state, or perioperative glucose control DKA or hyperosmolar crisis from the drip rate alone

Lactulose, rifaximin Hepatic encephalopathy or constipation in cirrhosis Hepatic encephalopathy without a provider diagnosis

• Naloxone Opioid toxicity or oversedation Poisoning versus adverse effect versus intent
• Acetylcysteine Acetaminophen toxicity protocol A finished poisoning diagnosis and intent
• CIWA-triggered benzodiazepines Alcohol withdrawal Withdrawal delirium or seizures unless documented
• Vancomycin plus piperacillin-tazobactam Concern for serious bacterial infection Sepsis or severe sepsis
• Stress-dose hydrocortisone Septic-shock adjunct or adrenal insufficiency Adrenal crisis
• Thiamine Nutritional risk in alcohol-use disorder Wernicke encephalopathy

Original scenario. Ms. N. has a body mass index of 17.4, a registered dietitian nutrition diagnosis of severe protein-calorie malnutrition, and a new megestrol order. No provider has diagnosed malnutrition. Megestrol is an indicator. The dietitian note is an indicator. The August 2026 ACDIS/AHIMA query brief allows Academy/ASPEN or GLIM criteria to be cited neutrally at the end of a template. It does not allow a yes/no query that introduces malnutrition from an RD note, and it does not allow “please document the MCC.” Use multiple-choice with clinically valid options and Other, please specify .

Original scenario. Mr. V. is on norepinephrine at 0.12 mcg/kg/min. The note says hypotension, fluids given. CDI may query for the type of shock if lactate, infection source, or cardiac failure indicators support a diagnosis. CDI may not assign septic shock from the infusion. If the provider documents cardiogenic shock after an anterior infarction, do not add septic shock just because a pressor is hanging.

Labs and imaging: the same rule, different pixels

Lactate, procalcitonin, white-cell count, bandemia, culture results, arterial blood gas, troponin, natriuretic peptide, ammonia, CD4 count, HIV RNA, sodium, creatinine, and bilirubin are all query fuel . A CT report of possible abscess, a chest radiograph of infiltrate, or an MRI of restricted diffusion is the same class of evidence: a diagnostic result. Pathology that the attending has not addressed is still a result looking for significance.

Section III of the Official Guidelines governs additional diagnoses in non-outpatient settings. Section III.B, Abnormal findings , states that abnormal findings (laboratory, x-ray, pathologic, and other diagnostic results) are not coded and reported unless the provider indicates their clinical significance . If the findings are outside the normal range and the provider has ordered other tests to evaluate the condition or has prescribed treatment, it is appropriate to ask the provider whether the abnormal finding should be added . The Guidelines note that this inpatient additional-diagnosis practice differs from outpatient coding of diagnostic tests interpreted by a provider. Do not import the outpatient test-coding habit onto an inpatient secondary diagnosis.

Signs and symptoms (Chapter 18 and other symptom codes) remain reportable when a related definitive diagnosis has not been established. That is a different rule from coding a raw sodium of 128 as hyponatremia with no provider statement. If the hospitalist writes “hyponatremia, 3% saline started,” significance is indicated. If the sodium sits at 128, nobody comments, and nobody treats it, you do not code the row. If the sodium is 118, 3% saline is ordered, and the problem list is silent, a query is appropriate.

Original scenario. An initial lactate is 4.2 mmol/L. The emergency department note never mentions lactate. No repeat is ordered. No bicarbonate is given. Do not assign lactic acidosis or severe sepsis from that cell. If a repeat lactate is trending and antibiotics plus fluids are underway for suspected infection, the lactate supports a sepsis query—it still does not assign the diagnosis.

Original scenario. Radiology reads “cannot exclude pulmonary embolism.” The team does not start anticoagulation, does not order a follow-up study, and documents that the filling defect is motion artifact. Do not code pulmonary embolism. If anticoagulation is started and the attending writes “PE,” the imaging was an indicator that became a diagnosis.

Abbreviations: standard ones versus dangerous ambiguity

CDI specialists live in abbreviated notes. Standard, unambiguous abbreviations that the facility recognizes—AKI, CKD, COPD, DKA when the context is diabetes, NSTEMI when the cardiologist has already said it—are ordinary medical writing. The exam still expects you to spell out a term on first use in educational material and to know when an abbreviation is not safe to interpret.

Dangerous ambiguity is the problem. MS can mean morphine sulfate, multiple sclerosis, or mitral stenosis. PT can mean physical therapy, prothrombin time, or patient. DC can mean discharge or discontinue. SS can mean sliding scale or Sjögren syndrome in the wrong specialty note. QD and QOD are on do-not-use lists because they are misread. U for units is misread as 0. MSO4 and MgSO4 are confused with each other. The Joint Commission Do Not Use list exists because these strings have harmed patients. For CDI, the harm is also a wrong diagnosis: coding multiple sclerosis from “MS improving” when the author meant morphine, or coding a coagulopathy from “PT tomorrow” when the author meant physical therapy.

• String Plausible meanings CDI action
• MS Morphine sulfate; multiple sclerosis; mitral stenosis Query; do not pick the MCC reading

PT Physical therapy; prothrombin time / INR; patient Use surrounding orders to see the ambiguity; still query if diagnosis is at stake

• DC Discharge; discontinue Confirm before acting on a stopped drug as underdosing
• NPO, PRN, BID Standard administration instructions Usually safe in MAR context
• AMS, CVA, CHF Common but unfinished clinical labels Treat as incomplete diagnoses; query for type

Original scenario. A progress note says “MS improving, start PT in AM.” The problem list has no neurologic disease. A physical-therapy order is placed. Interpreting MS as multiple sclerosis would manufacture a diagnosis. Interpreting PT as a clotting time would manufacture a coagulopathy. Query if a diagnosis hangs on the string; otherwise treat it as morphine and physical therapy only when the surrounding orders make those meanings unmistakable and no diagnosis is being assigned from the abbreviation.

Unspecified and “not otherwise specified” abbreviations in diagnoses (CHF, CVA, CKD, PNA) are a different CDI task: they are real conditions written without required specificity. That is a query for type and acuity, covered in the body-system chapters—not an invitation to decode a slang abbreviation into the highest-weighted code.

Building a compliant indicator-based query

Source the indicator to a location in the record: MAR, laboratory date and time, radiology impression, pathology, or nursing flowsheet. State what you observed without diagnosing. Offer only options the numbers can support—the 2026 brief’s example is not to offer hypernatremia for a sodium of 122. Include Other, please specify . Leave judgment with the provider. Do not mention CC, MCC, DRG, HAC, SOI, or ROM. If the diagnosis is already written and looks unsupported, use a clinical-validation multiple-choice pattern (confirmed with support, ruled out, no longer valid, alternative diagnosis, other). Verbal queries still need date, time, people, indicators with source, a nonleading statement, options if any, and a response that reaches the permanent health record before coding.

Technology-generated queries follow the same standard. An electronic prompt that says “lactate 4.2 — add lactic acidosis?” is still a query. If it introduces a diagnosis from a lab row with a yes/no, it is the wrong format.

Loading diagram... From drug, lab, or abbreviation to a reportable diagnosis

Exam-style habits

On test day you may open a drug handbook to confirm that megestrol is an appetite stimulant or that lactulose is used in hepatic encephalopathy. That lookup supports an indicator , not a code. You may open DRG Expert to see whether a named diagnosis is a CC or MCC. That lookup does not let you skip clinical validation. Practice one page of a chart: circle every drug, every abnormal number, and every abbreviation, then write which of them already have a provider diagnosis, which deserve a query, and which must be left alone under Section III.B. That exercise is the Domain II skill this section is built to teach.